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Abstract 
Where performance comparison of healthcare providers is of interest, characteristics of both patients 
and the health condition of interest must be balanced across providers for a fair comparison. This is 
unlikely to be feasible within observational data, as patient population characteristics may vary 
geographically and patient care may vary by characteristics of the health condition. We simulated data 
for patients and providers, based on a previously utilized real-world dataset, and separately considered 
both binary and continuous covariate-effects at the upper level. Multilevel latent class (MLC) modelling 
is proposed to partition a prediction focus at the patient level (accommodating ‘casemix’) and a causal 
inference focus at the provider level. The MLC model recovered a range of simulated Trust-level effects. 
Median recovered values were almost identical to simulated values for the binary Trust-level covariate, 
and we observed successful recovery of the continuous Trust-level covariate with at least 3 latent Trust 
classes. Credible intervals widen as the error variance increases. The MLC approach successfully 
partitioned modelling for prediction and for causal inference, addressing the potential conflict between 
these two distinct analytical strategies. This improves upon strategies which only adjust for differential 
selection. Patient-level variation and measurement uncertainty are accommodated within the latent 
classes.  
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Key Messages 
• Performance comparison of healthcare providers requires balance of patient characteristics and the 
health condition across providers, which is improbable due to heterogeneity. 
• We use simulated data to show how multilevel latent class (MLC) modelling can accommodate 
patient predicted ‘casemix’ and simultaneously evaluate the causal impact of provider-level factors, 
such as surgeon specialty or available beds. 
• We observed a generally successful recovery of simulated provider-level covariate effects, for both 
binary and continuous factors. 
• MLC modelling has the utility to partition different modelling approaches across a hierarchy, and 
there is much scope for further development. 
 
Abbreviations 
1P 1 Patient Class 
2T, 3T, 4T or 5T 1, 2, 4 or 5 Trust Classes !"  Trust-level coefficient 
CI Credible Interval 
MLC Multilevel Latent Class 
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Introduction 
Epidemiologic studies commonly focus on investigating the effect of an exposure on a health outcome at 
the individual level, while accommodating variation at the upper level of a hierarchy within a multilevel 
framework. Interest may alternatively lie in the evaluation of differences across an upper level, for 
instance when seeking to evaluate the performance of healthcare provision, or to assess the effect of 
provider-level factors on patient outcomes. In this situation, a fair comparison can only follow if 
individuals’ characteristics (such as demographics) and the severity of the health condition (‘casemix’) 
are balanced across providers. These circumstances are not very plausible for most aspects of healthcare 
provision due to inherent heterogeneity in the characteristics of individuals entering the healthcare 
system, dependent in part upon geography of residence.1 This patient-level heterogeneity, or ‘casemix’, 
leads to differential access to care, a form of differential selection. Further, we expect that patient care 
will vary by characteristics of the health condition (e.g. stage of diagnosis for cancer, previous case 
history of myocardial infarction) and features of their healthcare provider (e.g. available specialist, level 
of post-operative care), all of which likely impact patient-level health outcomes and contribute to any 
measured performance differences between providers.  
Different modelling approaches are required at each level of a hierarchy when accounting for both 
patient casemix (which involves prediction methodology) and the evaluation of potential causal 
influences operating at the upper level (which involves causal inference methodology). Strategies that 
adjust for differential selection (e.g. matching,2 stratification,3 regression3 and propensity score analysis4, 
5) are not readily adaptable to model separately the causal influences operating at the patient and 
provider levels; they may even introduce bias within such a complex analytical setting.6-8  
We propose multilevel latent class (MLC) modelling to exploit the inherent hierarchy of patients nested 
within healthcare providers, by partitioning the prediction focus at the individual level and the causal 
inference focus at the provider level. This paper extends the approach established in previous work9 to 
include putative causal covariates at the provider level (modelled here as National Health Service Trusts) 
to estimate the causal influence of provider characteristics on patient outcomes while accounting for the 
differential selection of patient casemix. We use simulated data to demonstrate proof of principle by 
exploring the extent to which the MLC model can recover simulated provider-level covariate causal 
effects. 
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Methods 
Data simulation 
We simulated data based on a previously utilized health dataset,9, 10 to reflect real-world data. The 
simulated data comprised 24,640 patients and 19 National Health Service Trusts. Figure 1 illustrates the 
overarching simulation approach to the patient and Trust levels. 
[Insert Figure 1 here] 
We first simulated the patient-level covariates age (at diagnosis), sex, and socio-economic status (the 
Townsend score of material deprivation) using a trivariate covariance matrix informed by real data. 
Values were drawn randomly from a normal distribution, and sex was categorized as male or female 
according to the median threshold. Age and socio-economic status were centered on their mean values; 
standard deviations were defined as per the real dataset: age standard deviation = 11.6, socio-economic 
status standard deviation = 3.18. Patient-level data were simulated to be homogeneous. Patients were 
then randomly assigned to Trusts, and Trust sizes were allowed to vary to reflect differing sizes of 
geographical area. 
At the Trust level, we simulated both binary and continuous effects, although we analyzed them 
separately. These effects represent competing and causally independent features operating at the 
provider level, for example whether specialist surgeons are available (binary) or the proportion of 
available beds (continuous). The binary Trust-level covariate was simulated to have parameterized values 
of -0.5 or +0.5, with some variability introduced by using a random normal distribution with a small 
standard deviation of 0.01. The continuous Trust-level covariate was simulated to have parameterized 
values ranging from -0.5 to +0.5. In each case, simulated values were randomly allocated across Trusts 
and duplication was allowed, to reflect real-world possibilities. 
We calculated continuous patient outcomes for each Trust-level covariate, by combining a linear 
predictor with a normally distributed error term (with mean = 0 and variance calculated as 33%, 50% or 
67% of the median variance of the error-free outcome). The linear predictor combined the patient- and 
Trust-level covariates using the equation: 
!#$ + (!'$ × )*+) + (!-$ × .+/) + (!0$ × 121) + (!" × 345.6- 8+9+8	;<9)4=)6+) !#$  is a constant term at the patient level i, !'$, !-$  and !0$  are the effects of the patient-level covariates 
‘age’, ‘sex’ and ‘socio-economic status’ respectively, and !"  is the coefficient effect of the Trust-level 
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covariate (binary or continuous) as set during simulation. Values of !#$, !'$, !-$  and !0$  are log odds 
values taken from previous analysis of the real-life health dataset, with !#$  = -0.0265, !'$  = 0.0547, !-$  = 
-0.1368 and !0$  = 0.0527. We investigated 5 coefficient values for each Trust-level covariate to show 
consistency of recovery from the simulated values. As an informed basis for analysis, we used the 
absolute effect of sex (0.137) for the binary Trust-level covariate, and the absolute effect of socio-
economic status (0.053) for the continuous Trust-level covariate. Table 1 summarizes the !"  values used 
for each Trust-level covariate. 
[Insert Table 1 here] 
In addition to the 5 Trust-level coefficient values (!") and the 3 error variances (33%, 50% or 67%), we 
used 3 simulation seeds to generate 45 different parameterizations of unique sets of 100 simulated 
datasets, for each of the binary and continuous Trust-level covariates. Table 2 summarizes the 
combinations used. 
[Insert Table 2 here] 
Multilevel Latent Class (MLC) analysis 
In standard latent class analysis,11, 12 observations are probabilistically assigned to classes with each 
observation having a probability of belonging to each latent class, and observations fully assigned across 
all classes. Multilevel latent class (MLC) models13, 14 are an extension of single-level latent class analysis 
with observations probabilistically assigned to latent classes at all levels of the hierarchy.  Assignment to 
classes at the lower level is based on similarities in characteristics,15 leading to homogeneous latent 
classes at this level, while latent classes at the upper level may be based on either similarities or 
differences, dependent on model specification and the research question sought. An optimum solution 
for all classes at all levels is sought simultaneously using maximum likelihood estimation.11 
While our simulation starts at the patient level and progresses upwards, modelling starts at the Trust 
level with a latent construct, followed by casemix adjustment. There is no direct overlap of simulation 
and analysis, allowing for a more robust assessment of the analytical strategy. Patients are grouped into 
latent classes based on similarities in characteristics, while for our research question, latent Trust classes 
are determined based on differences in patient characteristics. This approach yields Trust-level latent 
classes that are heterogeneous with respect to patient characteristics, such that each Trust-level class 
contains the same mixture of patient classes; Trust classes are effectively casemix ‘adjusted’.  
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We included simulated values of age, sex and socio-economic status in the fixed part of the model at the 
patient level, as is typical for a prediction model seeking to predict patient outcomes. We model at this 
level only to accommodate heterogeneity due to differential selection, not to make meaningful 
interpretation of patient-level covariates. Additional covariates (e.g. stage at diagnosis) may therefore be 
included, if available, without concern of invoking bias due to the reversal paradox,16 which would be an 
issue if we sought causal inference at this level.17, 18 Patient-level variation is incorporated via a single 
patient class. 
With patient casemix accommodated through standard prediction strategies, and the MLC model 
constraint that patient-level classes are balanced across Trust-level classes, any residual differences in 
patient outcomes are due to unmodelled causal effects operating at the Trust level. We simulated these 
effects, so our interest is in the comparison between simulated and recovered Trust-level covariate 
coefficient values. As a minimum, 2 Trust classes are required to distinguish outcome differences; more 
than 2 classes allow for greater flexibility in modelling variations at the Trust level. 
Trust-level coefficient recovery 
We modelled each simulated dataset using the approach described and calculated a weighted mean 
outcome for each Trust based on probabilistic assignment to Trust class. Values of the Trust-level 
coefficient (!") were recovered using single-level regression analysis. We repeated this process for all 
simulated datasets, and calculated medians and credible intervals (CI: 2.5%, 97.5%) over each set of 100 
repeated simulation datasets, for each MLC model scenario, simulated Trust-level coefficient parameter 
value, and error variance. 
Software 
Stata v14.219 was used to perform the simulations, collation of results and single-level linear regression 
analyses. Latent GOLD20, 21 was used for all latent variable models, which incorporates an adapted 
expectation-maximization algorithm13 for maximum likelihood estimation.  
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Results 
Binary Trust-level covariate 
Table 3 shows the results of the analyses for the binary Trust-level covariate. Results were consistent 
across simulation seeds; models contained 1 patient class (1P) and up to 4 Trust classes (4T). 
[Insert Table 3 here] 
For all combinations, the simulated values of the Trust-level coefficient (!") were within credible 
intervals for each recovered !"  value, and results were consistent across different models and error 
variances. The median recovered !"  was almost identical to the simulated !"  for all simulated values 
except the lowest, regardless of error variance or MLC model. In general, as the error variance increases, 
the credible intervals became gradually wider, as would be expected, but differences were small. 
For the lowest simulated !"  value of 0.027, the recovered !"  value reduces as the error variance 
increases (from 0.017-0.018 at the 33% error variance to 0.012-0.013 at the 67% error variance), and 
some !"  coefficients could not be recovered due to some simulated datasets yielding the same 
probability of class membership for each of the 19 Trusts. We hypothesize that, at very small values of !", the noise introduced when simulating data dominates the value of the !"  coefficient and the 
modelling process is unable to divide the Trusts into identifiably different Trust classes. The number of 
datasets excluded was small (0-1 at the 33% error variance, 0-5 at the 50% error variance, and 4-11 at 
the 67% error variance), but some bias may have occurred. 
Figure 2 shows the results from table 3 plotted by error variance, demonstrating that the line of equality 
(where recovered !"  equals simulated !") lies almost exactly on the data points and is well within the 
credible intervals. We included all MLC models and made no distinction between the number of Trust 
classes. 
[Insert Figure 2 here] 
Continuous Trust-level covariate 
Table 4 shows the results of the analyses for the continuous Trust-level covariate. Results were 
consistent across simulation seeds; models contained one patient class (1P) and up to five Trust classes 
(5T), to reflect the gradual improvement seen as the number of Trust classes increase, revealing how 
model robustness may warrant more Trust classes than deemed most parsimonious (in contrast to 
typical latent class modelling strategies that may favor fewer classes to minimize model complexity). 
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[Insert Table 4 here] 
For all combinations, the median recovered values of the Trust-level coefficient (!") were lower than 
those simulated, although simulated values were within the credible intervals for each recovered !"  
value for models with 3 Trust classes or more. Again, credible intervals widen as the error variance 
increases, but here they also widen as the simulated !"  value increases. Estimates were better for 
smaller values of the error variance, indicating that an increase in simulated error variance may be 
dominating the value of the !"  coefficient such that the modelling process is less able to separate the 
Trusts into distinct Trust classes. For the larger simulated !"  values, estimates improve as the number of 
Trust classes increase, and we see this pattern for all values of the error variance. We anticipated this 
relationship, as more Trust classes are required to robustly differentiate differences between values of 
the continuous Trust-level covariate across Trusts. 
For the lowest simulated !"  value of 0.027, the median returned value does not differ much across MLC 
models, and the credible intervals increase only slightly as the error variance increases. There was a 
similar, though attenuated, pattern seen for the second lowest simulated !"  value of 0.053. Again, some 
datasets were excluded for the same reasons as described for the binary Trust-level covariate, both for 
the lowest !"  value of 0.027 (41-53 at the 33% error variance, 43-57 at the 50% error variance, and 46-
61 at the 67% error variance), and the second lowest !"  value of 0.053 (0-4 at the 50% error variance, 
and 2-6 at the 67% error variance). We therefore excluded the lowest simulated value of !"  from any 
further investigation into the relationship between simulated and recovered values, as too few datasets 
are included to rely on the results observed. 
Figures 3-5 show the results from table 4, excluding the lowest value of !"  = 0.011, plotted separately by 
error variance, and showing the gradually improving relationship between the simulated and recovered 
values of the Trust-level coefficient as the number of Trust classes increase. 
[Insert Figures 3-5 here] 
Sensitivity analyses 
In real-world situations, Trust sizes might vary, the division of the binary Trust-level covariate (currently 
±0.5) might differ more than we have initially simulated, and the continuous Trust-level covariate 
(currently ranging from -0.5 to +0.5) may be duplicated across Trusts. To assess the sensitivity of our 
simulations, we amended each of these aspects individually; we found that none of these choices 
affected model outcomes.  
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There was also little difference in the recovered values of !"  obtained when we increased the number of 
simulation datasets to 1,000, supporting the use of 100 simulated datasets per combination of 
simulation parameters. 
We considered the implication of simulating 50 Trusts (opposed to 19), making no other concurrent 
changes to the simulation process. We used the same MLC models but modelled only 50% error 
variance, to assess changes in recovered estimates without needing to replicate the entire set of results. 
Recovered estimates were reduced for lower simulated !"  values when we considered a binary Trust-
level covariate and for all simulated !"  values when we considered a continuous Trust-level covariate. 
Although all simulated !"  values (except the lowest) remained within credible intervals of the recovered 
values for the binary Trust-level covariate, this was no longer the case for the continuous Trust-level 
covariate, due to a general narrowing of credible intervals throughout. We also modelled with 1 patient-
class and 10 Trust-classes for both 19 and 50 Trusts (but considered only 50% error variance and 1 
simulation seed to reduce computational requirements). Results did not show improvement compared 
to the 1 patient-class 5 Trust-class MLC models for either 19 or 50 Trusts.  
Discussion 
By adopting the MLC modelling strategy, we have shown a successful recovery of Trust-level coefficient 
parameter values. Simulated values were within credible intervals of the recovered values throughout 
for the binary Trust-level covariate, and when the number of Trust classes were at least 3 for the 
continuous Trust-level covariate. We observed some attenuation of effect (i.e. median estimates were 
lower than simulated true values) for the continuous Trust-level covariate, which is important when 
considering larger numbers of Trusts. In this situation, effects seen may be lower than the ‘true’ effects, 
particularly for greater error variances and smaller numbers of Trust classes. Whilst simulations with 50 
Trusts can support more Trust classes compared to those with 19 Trusts, there is no evidence that 
increasing the number of Trust classes is a solution.  
Lower simulated values of the Trust-level coefficients were not recovered as well as higher values, and 
datasets were excluded when these coefficients could not be recovered at all. It is possible that the 
variability introduced in the covariates during simulation dominates the coefficient parameter value such 
that it is harder to estimate within the modelling process. Bias may also exist due to dataset exclusions. It 
is reassuring, therefore, that these values remain within credible intervals of the recovered values. 
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The illustrated MLC approach has several advantages. We have partitioned modelling for prediction 
(casemix adjustment) and for causal inference (assessing the putative causal impact of Trust 
characteristics) at different levels of the data structure, thus performing adjustment for differential 
selection at the patient level while allowing for investigation of causal insights at the Trust level. This 
serves to overcome the potential conflict between two distinctly separate analytical strategies. 
Uncertainty surrounding class membership is implicit within the latent classes, since observations may 
belong to all classes, with probabilities determined empirically; the latent class approach therefore 
accommodates uncertainty better than standard regression modelling. Unlike other casemix adjustment 
strategies, this approach accommodates both patient-level variation due to unmeasured covariates, and 
measurement uncertainty within observed covariates, all within the latent constructs adopted. 
There is much scope for extension and further development. For simplification, and proof of principle, 
we analyzed competing and causally independent binary and continuous Trust-level covariate effects 
separately, making the assessment of total causal effect straightforward. Multiple covariates can logically 
be included in combination at the Trust level within a robust causal framework,22 supported by the 
construction of a multivariable directed acyclic graph (DAG)23 to resolve which covariates are required to 
address separate research questions pertaining to the putative causal impacts of each covariate in the 
DAG.24 The same modelling framework may accommodate a binary outcome variable, although the fixed 
binomial error variance of >- 3⁄  at the patient level has implications on the effect of the variance 
structure at higher levels, which may serve to distort the relationship between simulated and recovered 
values. Also for simplification, we simulated patient-level data to be homogeneous, and modelled using 
only 1 patient class. The MLC approach allows for any number of patient classes to be specified, to 
ensure casemix balance across Trust classes by accommodating patient heterogeneity. More complex 
simulations with mixtures of patient subgroups can therefore be explored in future evaluation. 
Additional complexities in casemix (e.g. treatment variables) can also be incorporated, in combination 
with all other potential complexities – this is not typically considered within standard casemix modelling 
strategies, yet arguably it should be if we assume that the treatment given should part explain the 
heterogeneity in patient outcomes that are observed. 
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Tables 
Table 1. Trust-level Coefficient Values for the Binary and Continuous Trust-level Covariates. 
!"  Effect !"  Coefficient Values Binary Trust-level 
Covariate 
Continuous Trust-level 
Covariate 
One fifth effect 0.027 0.011 
Effect of sex or deprivation 0.137 0.053 
Additional value 0.250 0.120 
Additional value 0.500 0.200 
Five times effect 0.684 0.264 !" – Trust-level coefficient value 
 
Table 2. Summary of Combinations Used in Data Simulations 
!"  Coefficient  Error variance Simulation seeds Binary Trust- level covariate Continuous Trust-level covariate 
 33% 1, 2, 3   
One fifth effect 50% 1, 2, 3 9 sets of 100 
datasets 
9 sets of 100 
datasets  67% 1, 2, 3   
 33% 1, 2, 3   
Effect of sex or deprivation 50% 1, 2, 3 9 sets of 100 
datasets 
9 sets of 100 
datasets  67% 1, 2, 3   
 33% 1, 2, 3   
Additional value 50% 1, 2, 3 9 sets of 100 
datasets 
9 sets of 100 
datasets  67% 1, 2, 3   
 33% 1, 2, 3   
Additional value 50% 1, 2, 3 9 sets of 100 
datasets 
9 sets of 100 
datasets  67% 1, 2, 3   
 33% 1, 2, 3   
Five times effect 50% 1, 2, 3 9 sets of 100 
datasets 
9 sets of 100 
datasets  67% 1, 2, 3   !" – Trust-level coefficient value
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Table 3. Simulated and Recovered Values of the Trust-level Coefficient for the Binary Trust-level Covariate 
Simulated !"  
Coefficient 
MLC 
Model 
Recovered !"  Coefficient 
Error variance 33% Error Variance 50% Error Variance 67% 
Mediana CI Mediana CI Mediana CI 
 1P-2T 0.017 0.005, 0.030 0.014 0.002, 0.029 0.012 0.002, 0.028 
0.027 1P-3T 0.018 0.005, 0.031 0.015 0.003, 0.030 0.013 0.002, 0.029 
 1P-4T 0.018 0.005, 0.031 0.015 0.003, 0.030 0.013 0.002, 0.029 
 1P-2T 0.137 0.126, 0.146 0.136 0.123, 0.148 0.136 0.119, 0.149 
0.137 1P-3T 0.136 0.126, 0.146 0.136 0.123, 0.148 0.136 0.118, 0.150 
 1P-4T 0.136 0.126, 0.146 0.136 0.123, 0.149 0.136 0.118, 0.150 
 1P-2T 0.250 0.239, 0.259 0.250 0.237, 0.261 0.250 0.235, 0.263 
0.250 1P-3T 0.250 0.239, 0.259 0.250 0.237, 0.261 0.249 0.235, 0.263 
 1P-4T 0.250 0.239, 0.259 0.250 0.237, 0.261 0.249 0.235, 0.263 
 1P-2T 0.499 0.489, 0.509 0.499 0.486, 0.511 0.499 0.484, 0.513 
0.500 1P-3T 0.499 0.489, 0.509 0.499 0.486, 0.511 0.499 0.484, 0.512 
 1P-4T 0.499 0.489, 0.509 0.499 0.486, 0.511 0.499 0.485, 0.513 
 1P-2T 0.683 0.672, 0.693 0.683 0.670, 0.695 0.683 0.668, 0.697 
0.684 1P-3T 0.683 0.673, 0.693 0.683 0.670, 0.695 0.683 0.668, 0.696 
 1P-4T 0.683 0.673, 0.693 0.683 0.670, 0.695 0.683 0.668, 0.697 
1P – 1 Patient Class; 2T, 3T or 4T – 2, 3 or 4 Trust Classes;  !" – Trust-level Coefficient Value; CI – Credible Interval 
amedian averaged over 3 simulation seeds  
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Table 4. Simulated and Recovered Values of the Trust-level Coefficient for the Continuous Trust-level Covariate 
Simulated !"  
Coefficient 
MLC 
Model 
Recovered !"  Coefficient 
Error variance 33% Error Variance 50% Error Variance 67% 
Mediana CI Mediana CI Mediana CI 
0.011 
1P-2T 0.003 -0.001, 0.013 0.003 -0.002, 0.015 0.003 -0.003, 0.017 
1P-3T 0.003 -0.001, 0.014 0.003 -0.002, 0.015 0.003 -0.002, 0.017 
1P-4T 0.003 -0.001, 0.014 0.003 -0.002, 0.015 0.003 -0.002, 0.017 
1P-5T 0.003 -0.001, 0.014 0.003 -0.002, 0.015 0.004 -0.003, 0.017 
0.053 
1P-2T 0.032 0.011, 0.051 0.029 0.008, 0.052 0.027 0.003, 0.052 
1P-3T 0.036 0.012, 0.056 0.031 0.008, 0.055 0.028 0.004, 0.055 
1P-4T 0.036 0.012, 0.056 0.032 0.008, 0.055 0.028 0.004, 0.054 
1P-5T 0.036 0.012, 0.056 0.031 0.007, 0.055 0.028 0.005, 0.054 
0.120 
1P-2T 0.090 0.063, 0.113 0.087 0.058, 0.115 0.085 0.054, 0.115 
1P-3T 0.105 0.079, 0.124 0.101 0.071, 0.126 0.098 0.062, 0.126 
1P-4T 0.107 0.084, 0.127 0.103 0.073, 0.126 0.099 0.063, 0.127 
1P-5T 0.109 0.085, 0.127 0.104 0.073, 0.129 0.100 0.063, 0.129 
0.200 
1P-2T 0.153 0.113, 0.184 0.152 0.111, 0.185 0.151 0.109, 0.186 
1P-3T 0.182 0.154, 0.201 0.180 0.148, 0.203 0.178 0.143, 0.205 
1P-4T 0.188 0.165, 0.207 0.186 0.159, 0.209 0.183 0.149, 0.209 
1P-5T 0.191 0.168, 0.210 0.188 0.161, 0.210 0.186 0.154, 0.212 
0.264 
1P-2T 0.201 0.153, 0.241 0.202 0.149, 0.242 0.202 0.147, 0.243 
1P-3T 0.240 0.207, 0.263 0.240 0.203, 0.264 0.238 0.202, 0.266 
1P-4T 0.250 0.223, 0.269 0.249 0.218, 0.271 0.248 0.213, 0.274 
1P-5T 0.254 0.230, 0.274 0.252 0.225, 0.277 0.251 0.220, 0.277 
1P – 1 Patient Class; 2T, 3T, 4T or 5T – 2, 3, 4 or 5 Trust Classes;  !" – Trust-level Coefficient Value; CI – Credible Interval 
amedian averaged over 3 simulation seeds
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Figures 
 
 
 
 
 
 
 
 
 
 
Figure 1. Overarching simulation approach to the patient and Trust levels 
μ – mean, σ – standard deviation, SES – socio-economic status, N – total number of unique observations at patient 
or Trust level 
  
 
 
Continuous covariate; 
range -0.5 to +0.5 
Binary covariate;  
value ±0.5 
Age at diagnosis 
Continuous; 
µ=0, σ=11.6 
SES 
Continuous; 
µ=0, σ=3.18 
Sex 
Binary;  
M/F 
Linear predictor 
Continuous Outcome 
Error 
Patient level N=24,640 
Trust level N=19 
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Figure 2. Plot showing !" relationship for the binary Trust-level covariate 
 
Figure 3. Plot showing !" relationship for the continuous Trust-level covariate; 33% error variance 
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Figure 4. Plot showing !" relationship for the continuous Trust-level covariate; 50% error variance 
  
Figure 5. Plot showing !" relationship for the continuous Trust-level covariate; 67% error variance 
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